GHAZALEH ESKANDARI to Aged
This is a "connection" page, showing publications GHAZALEH ESKANDARI has written about Aged.
Connection Strength
0.019
-
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors. Clin Cancer Res. 2020 03 15; 26(6):1237-1246.
Score: 0.012
-
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis. Disabil Rehabil. 2013 Aug; 35(18):1509-12.
Score: 0.007